Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape

Current Opinion in Colloid and Interface Science

Volumn 14, Issue 5, 2009, Pages 349-355

  Bechinger, Burkhard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Bilayer; Detergent; Electrostatics; Fatty acyl chain; Lipid packing; Membrane surface charge; Order parameter; Penetration depth; Peptide pore formation; Peptide lipid interactions; Phase diagram; Phospholipid membrane; Supramolecular assembly

Indexed keywords

BILAYER; FATTY ACYL CHAIN; MEMBRANE SURFACE CHARGE; ORDER PARAMETER; PENETRATION DEPTH; PEPTIDE-LIPID INTERACTIONS; PHOSPHOLIPID MEMBRANE; SUPRAMOLECULAR ASSEMBLY;

CHARGED PARTICLES; DETERGENTS; DISSOCIATION; DISTANCE MEASUREMENT; DRUG INTERACTIONS; ELECTROSTATICS; LIPID BILAYERS; MEMBRANES; MORPHOLOGY; PEPTIDES; PHASE DIAGRAMS; PHASE INTERFACES; PHOSPHOLIPIDS; POLYPEPTIDES; PORE SIZE; SUPRAMOLECULAR CHEMISTRY; SURFACE CHARGE;

AMINES;

ALAMETHICIN; ALANYLGLYCYLALANYLISOLEUCYLALANINE; ALANYLLEUCYLALANYLLEUCYLHISTIDINE; ARGINYLASPARTYLGLYCYLISOLEUCYLISOLEUCINE; CECROPIN; GLYCYLISOLEUCYLGLYCYLALANYLVALINE; GLYCYLISOLEUCYLGLYCYLLYSYLPHENYLALANINE; GLYCYLLYSYLISOLEUCYLALANYLLYSINE; GLYCYLMETHIONYLALANYLSERYLLYSINE; GLYCYLPHENYLALANYLPHENYLALANYLALANYLLEUCINE; HISTIDYLLEUCYLALANYLHISTIDYLLEUCINE; ISOLEUCYLPROLYLLYSYLISOLEUCYLISOLEUCINE; LEUCYLHISTIDYLSERYLALANYLLYSINE; LEUCYLLYSYLVALYLLEUCYLTHREONINE; LYSYLLYSYLALANYLLEUCYLLEUCINE; LYSYLLYSYLISOLEUCYLGLUTAMYLLYSINE; LYSYLPHENYLALANYLGLYCYLLYSYLALANINE; LYSYLTRYPTOPHYLLYSYLLEUCYLPHENYLALANINE; MAGAININ DERIVATIVE; MELITTIN; MEMBRANE LIPID; PARDAXIN; PHENYLALANYLVALYLGLYCYLGLUTAMYLISOLEUCINE; PLEUROCIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; SERYLSERYLPROLYLLEUCYLPHENYLALANINE; THREONYLGLYCYLLEUCYLPROLYLALANINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALYLALANYLLEUCYLLYSYLALANINE; VALYLGLYCYLGLUTAMINYLASPARAGINYLISOLEUCINE;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ELECTRICITY; LIPID BILAYER; LIPID COMPOSITION; PROTEIN LIPID INTERACTION; REVIEW; SURFACE CHARGE; TEMPERATURE;

EID: 68749115077     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cocis.2009.02.004     Document Type: Review

References (98)

1. Boman H.G. J Intern Med 254 (2003) 197-215
2. Zasloff M. Nature 415 (2002) 389-395. This paper illustrates how the amphipathic distribution of side chains in the membrane-associated conformation rather than a particular secondary structure or amino acid sequence is important for antimicrobial action.
3. http://www.bbcm.univ.trieste.it/~tossi/amsdb.html or http://aps.unmc.edu/AP/main.php.
4. Mason A.J., Moussaoui W., Abdelrhaman T., Boukhari A., Bertani P., Marquette A., et al. J Biol Chem 284 (2009) 119-133
5. Blondelle S.E., and Lohner K. Biopolymers 55 (2000) 74-87
6. Baker M.A., Maloy W.L., Zasloff M., and Jacob L.S. Cancer Res 53 (1993) 3052-3057
7. Lehrer R.I. Nat Rev Microbiol 2 (2004) 727-738
8. Hwang P.M., and Vogel H.J. Biochem Cell Biol 76 (1998) 235-246. Structural data of antimicrobial peptides are shown which are indicative of the amphipathic distribution of charged/polar and hydrophobic residues.
9. Vunnam S., Juvvadi P., Rotondi K.S., and Merrifield R.B. Int J Pept Protein Res 51 (1998) 38-44
10. Latal A., Lehrer R.I., Harwig S., and Lohner K. Prog Biophys Mol Biol 65 (1996) 121
11. Lee K.H. Curr Pharm Des 8 (2002) 795-813
12. Beven L., Castano S., Dufourcq J., Wieslander A., and Wroblewski H. Eur J Biochem 270 (2003) 2207-2217
13. Cheng R.P., Gellman S.H., and DeGrado W.F. Chem Rev 101 (2001) 3219-3232
14. Arvidsson P.I., Frackenpohl J., Ryder N.S., Liechty B., Petersen F., Zimmermann H., et al. Chembiochem 2 (2001) 771-773
15. Epand R.F., Umezawa N., Porter E.A., Gellman S.H., and Epand R.M. Eur J Biochem 270 (2003) 1240-1248
16. Violette A., Fournel S., Lamour K., Chaloin O., Frisch B., Briand J.P., et al. Chem Biol 13 (2006) 531-538
17. Patch J.A., and Barron A.E. J Am Chem Soc 125 (2003) 12,092-12,093. References [13-17] describe the antimicrobial activities of peptide mimetics and thereby conceptually confirm the importance of amphipathic structure rather than a detailed conformational arrangement.
18. Tew G.N., Clements D., Tang H.Z., Arnt L., and Scott R.W. Biochim Biophys Acta-Biomembr 1758 (2006) 1387-1392. The antimicrobial action and selectivity of cationic polymers is described. Developing this concept further may allow the future design of easy to produce antimicrobial compounds.
19. Oh J.E., Hong S.Y., and Lee K.H. J Pept Res 54 (1999) 129-136
20. Westerhoff H.V., Juretic D., Hendler R.W., and Zasloff M. Proc Natl Acad Sci USA 86 (1989) 6597-6601
21. Lehrer R.I., Barton A., Daher K.A., Harwig S.S., Ganz T., and Selsted M.E. J Clin Invest 84 (1989) 553-561
22. Matsuzaki K., Sugishita K., Harada M., Fujii N., and Miyajima K. Biochim Biophys Acta 1327 (1997) 119-130
23. da Silva Jr. A., and Teschke O. Biochim Biophys Acta 1643 (2003) 95-103
24. Bechinger B. Biochim Biophys Acta 1462 (1999) 157-183. A new concept is presented where phase diagrams describe the different membrane morphologies that result from the interactions of antimicrobial peptides with membranes. The paper reviews a large amount of biophysical and biological data in support of the model.
25. Shai Y. Biochim Biophys Acta 1462 (1999) 55-70. Based on experimental observations that many cationic antimicrobial peptides align parallel to the membrane surface, first shown experimentally in the early 1990s (e.g. [35]), the carpet model is presented and discussed.
26. Brogden K.A. Nat Rev Microbiol 3 (2005) 238-250
27. Hale J.D., and Hancock R.E. Expert Rev Anti Infect Ther 5 (2007) 951-959. References [26] and [27] emphasize that the antimicrobial action of cationic peptides can be due to membrane permeability increases but also other interactions within the cell interior. Nevertheless membrane interactions are important for the peptides to enter the cells and for selectivity.
28. Jing W., Svendsen J.S., and Vogel H.J. Biochem Cell Biol 84 (2006) 312-326
29. Hong M. Acc Chem Res 39 (2006) 176-183. Important structural work on β-sheet antimicrobial peptides associated with lipid bilayers.
30. Porcelli F., Buck-Koehntop B.A., Thennarasu S., Ramamoorthy A., and Veglia G. Biochemistry 45 (2006) 5793-5799
31. Boland M.P., and Separovic F. Biochim Biophys Acta 1758 (2006) 1178-1183
32. Resende J.M., Moraes C.M., Prates M.V., Cesar A., Almeida F.C.L., Mundim N.C.C.R., et al. Peptides 29 (2008) 1633-1644
33. Verly R.M., Mendonca de Moraes C., Resende J.M., Aisenbrey C., Bemquemer M.P., Pilo-Veloso D., Valente A.P., de Alemida F.C., Bechinger B., Biophys. J. (in press) 2009.
34. Wieprecht T., Apostolov O., Beyermann M., and Seelig J. J Mol Biol 294 (1999) 785-794. The driving forces that emerge from random coil-helix structural transitions during the association of magainin with membranes is evaluated in a quantitative manner. This data has important consequences for the design of new compounds.
35. Bechinger B., Kim Y., Chirlian L.E., Gesell J., Neumann J.M., Montal M., et al. J Biomol NMR 1 (1991) 167-173
36. Pouny Y., Rapaport D., Mor A., Nicolas P., and Shai Y. Biochemistry 31 (1992) 12,416-12,423
37. Gazit E., Lee W.J., Brey P.T., and Shai Y. Biochemistry 33 (1994) 10,681-10,692
38. Matsuzaki K., Murase O., Tokuda H., Funakoshi S., Fujii N., and Miyajima K. Biochemistry 33 (1994) 3342-3349. Early quantitative data on the membrane penetration depth of magainin derivatives provides important information for our understanding of the peptide-lipid interactions.
39. Bechinger B., and Lohner K. Biochim Biophys Acta 1758 (2006) 1529-1539. The comparison of amphipathic peptides with detergents and the description of antimicrobial peptide-lipid systems by phase diagrams are developed in detail including the molecular shape concept.
40. Dathe M., Schümann M., Wieprecht T., Winkler A., Beyermann M., Krause E., et al. Biochemistry 35 (1996) 12,612-12,622
41. Dathe M., Nikolenko H., Meyer J., Beyermann M., and Bienert M. FEBS Lett 501 (2001) 146-150
42. Sharon M., Oren Z., Shai Y., and Anglister J. Biochemistry 38 (1999) 15,305-15,316
43. Tachi T., Epand R.F., Epand R.M., and Matsuzaki K. Biochemistry 41 (2002) 10,723-10,731
44. Wieprecht T., Dathe M., Epand R.M., Beyermann M., Krause E., Maloy W.L., et al. Biochemistry 36 (1997) 12,869-12,880
45. Cruciani R.A., Barker J.L., Raghunathan G., Guy H.R., Zasloff M., and Stanley E.F. Eur J Pharmacol 226 (1992) 287-296
46. Duclohier H., Molle G., and Spach G. Biophys J 56 (1989) 1017-1021
47. Christensen B., Fink J., Merrifield R.B., and Mauzerall D. Proc Natl Acad Sci USA 85 (1988) 5072-5076
48. Thogersen L., Schiott B., Vosegaard T., Nielsen N.C., and Tajkhorshid E. Biophys J 95 (2008) 4337-4347
49. Salnikov E.S., Friedrich H., Li X., Bertani P., Reissmann S., Hertweck C., et al. Biophys J 96 (2009) 86-100
50. Matsuzaki K., Murase O., Fujii N., and Miyajima K. Biochemistry 35 (1996) 11,361-11,368
51. Ludtke S.J., He K., Heller W.T., Harroun T.A., Yang L., and Huang H.W. Biochemistry 35 (1996) 13,723-13,728. Based on neutron scattering experiments the formation of toroidal pores is suggested at high peptide-to-lipid ratios.
52. Wieprecht T., Dathe M., Epand R.M., Beyermann M., Krause E., Maloy W.L., et al. Biochemistry 36 (1997) 12,869-12,880
53. Juretic D., Hendler R.W., Kamp F., Caughey W.S., Zasloff M., and Westerhoff H.V. Biochemistry 33 (1994) 4562-4570
54. Silvestro L., Gupta K., Weiser J.N., and Axelsen P.H. Biochemistry 36 (1997) 11,452-11,460
55. Hallock K.J., Lee D.K., and Ramamoorthy A. Biophys J 84 (2003) 3052-3060. Biophysical investigations demonstrate the important role of molecular shape and membrane curvature strain for cationic antimicrobial peptide-membrane interactions.
56. Bechinger B. Biochim Biophys Acta 1712 (2005) 101-108
57. Madden T.D., and Cullis P.R. Biochim Biophys Acta 684 (1982) 149-153
58. Müller K., Lipka G., Lohner K., and Laggner P. Thermochimica Acta 94 (1985) 187-197
59. Leontiadou H., Mark A.E., and Marrink S.J. J Am Chem Soc 128 (2006) 12,156-12,161. The molecular modelling of a magainin-lipid system visualises the dynamic interactions, the lack of a defined peptide structure, the absence of transmembrane helix alignments and the absence of peptide-peptide contacts during the increase of membrane permeability.
60. Miteva M., Andersson M., Karshikoff A., and Otting G. FEBS Lett 462 (1999) 155-158
61. Schlieper P., and De Robertis E. Arch Biochem Biophys 184 (1977) 204-208
62. Alder G.M., Arnold W.M., Bashford C.L., Drake A.F., Pasternak C.A., and Zimmermann U. Biochim Biophys Acta 1061 (1991) 111-120
63. Antonov V.F., Petrov V.V., Molnar A.A., Predvoditelev D.A., and Ivanov A.S. Nature 283 (1980) 585-586
64. Kaufmann K., and Silman I. Biophys Chem 18 (1983) 89-99
65. Yoshikawa K., Fujimoto T., Shimooka T., Terada H., Kumazawa N., and Ishii T. Biophys Chem 29 (1988) 293-299
66. Woodbury D.J. J Membr Biol 109 (1989) 145-150
67. Israelachvili J.N., Marcelja S., and Horn R.G. Q Rev Biophys 13 (1980) 121-200
68. Cullis P.R., and De Kruijff B. Biochim Biophys Acta 559 (1979) 399-420
69. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., Miyajima K., et al. Biochemistry 37 (1998) 11,856-11,863. Biophysical investigations demonstrate the important role of molecular shape and membrane curvature strain for cationic antimicrobial peptide-membrane interactions.
70. Ludtke S., He K., and Huang H. Biochemistry 34 (1995) 16,764-16,769
71. Münster C., Lu Y., Schinzel S., Bechinger B., and Salditt T. Eur Biophys J 28 (1999) 683-688
72. Chen F.Y., Lee M.T., and Huang H.W. Biophys J 84 (2003) 3751-3758
73. Mecke A., Lee D.K., Ramamoorthy A., Orr B.G., and Banaszak Holl M.M. Biophys J 89 (2005) 4043-4050
74. Wi S., and Kim C. J Phys Chem B 112 (2008) 11,402-11,414
75. Salnikov E.S., Mason A.J., and Bechinger B. Biochimie 91 (2009) 734-743
76. Pott T., Maillet J.C., Abad C., Campos A., Dufourcq J., and Dufourc E.J. Chem Phys Lipids 109 (2001) 209-223
77. Ramamoorthy A., Thennarasu S., Lee D.K., Tan A., and Maloy L. Biophys J 91 (2006) 206-216
78. Mason A.J., Martinez A., Glaubitz C., Danos O., Kichler A., and Bechinger B. FASEB J 20 (2006) 320-322. The correlation between peptide-induced lipid disorder and biological activity is demonstrated. Furthermore, data are presented that indicate an interaction of cationic peptides with domains rich in acidic phospholipids.
79. Bechinger B. J Mol Biol 263 (1996) 768-775
80. Aisenbrey C., Kinder R., Goormaghtigh E., Ruysschaert J.M., and Bechinger B. J Biol Chem 281 (2006) 7708-7716
81. Aisenbrey C., Goormaghtigh E., Ruysschaert J.M., and Bechinger B. Mol Membr Biol 23 (2006) 363-374
82. Mason A.J., Gasnier C., Kichler A., Prevost G., Aunis D., Metz-Boutigue M.H., et al. Antimicrob Agents Chemother 50 (2006) 3305-3311
83. Mason A.J., Leborgne C., Moulay G., Martinez A., Danos O., Bechinger B., et al. J Control Release 118 (2007) 95-104
84. Mason A.J., Husnal-Chotimah I.N., Bertani P., and Bechinger B. Mol Membr Biol 23 (2006) 185-194
85. Tytler E.M., Anantharamaiah G.M., Walker D.E., Mishra V.K., Palgunachari M.N., and Segrest J.P. Biochemistry 34 (1995) 4393-4401
86. Jin Y., Hammer J., Pate M., Zhang Y., Zhu F., Zmuda E., et al. Antimicrob Agents Chemother 49 (2005) 4957-4964
87. Hallock K.J., Lee D.K., Omnaas J., Mosberg H.I., and Ramamoorthy A. Biophys J 83 (2002) 1004-1013. Biophysical investigations demonstrate the important role of molecular shape and membrane curvature strain for cationic antimicrobial peptide-membrane interactions.
88. Dufourc E.J. J Chem Biol 1 (2008) 63-77
89. Nakajima Y., Qu X., and Natori S. J Biol Chem 262 (1987) 1665-1669
90. Mason A.J., Marquette A., and Bechinger B. Biophys J 93 (2007) 4289-4299
91. Williams R.W., Starmann R., Taylor K.M.P., Gable K., Beeler T., Zasloff M., et al. Biochemistry 29 (1990) 4490-4496
92. Matsuzaki K., Harada M., Funakoshi S., Fujii N., and Miyajima K. Biochim Biophys Acta 1063 (1991) 162-170
93. Wenk M., and Seelig J. Biochemistry 37 (1998) 3909-3916
94. Wieprecht T., Beyermann M., and Seelig J. Biochemistry 38 (1999) 10,377-10,378. The quantitative analysis of magainin 2 membrane partitioning with neutral and negatively charged membranes described in references [93] and [94] reveals the importance of electrostatic interactions in increasing the peptide concentration close to the membrane surface and ultimately provides an explanation for the selective killing of bacterial cells.
95. Bechinger B. Crit Rev Plant Sci 23 (2004) 271-292
96. Vogt T.C.B., and Bechinger B. J Biol Chem 274 (1999) 29,115-29,121. By using the designed antimicrobial peptides presented in reference [79] it is demonstrated that the membrane and cell lytic activities of in-plane oriented amphipathic peptides are more pronounced than their transmembrane state. Furthermore, it is shown that cationic peptides associated with acidic PG are less membrane disruptive when compared to zwitterionic PC. However, this effect is more than compensated by the increased membrane association due to the negative membrane surface charge density (cf. [93,94]).
97. Bechinger B. Cell Mol Life Sci 65 (2008) 3028-3039
98. Hancock R.E., and Chapple D.S. Antimicrob Agents Chemother 43 (1999) 1317-1323